Skip to evidence report

MAC.MDM.complement_resolving: Studies — page 12

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,931 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 11,001–12,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for MAC.MDM.complement_resolving
#Trait / studyIndividual trait IDMean IC score
11001DTI TBSS L2 Uncinate fasciculus RGCST903845203.91e-03
11002Pain type(s) experienced in last month - None of the above | PainUKBB000006313.91e-03
11003BA-exvivo rh area V2GCST900032313.91e-03
11004ICD10 N81: Female genital prolapseGCST904542143.91e-03
11005Migraine without auraFING000008213.90e-03
11006Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T235ECGA0002353.89e-03
11007HippSubfield lh volume CA4-headGCST900026823.87e-03
11008DTI autoptx MD atr l tractGCST903852223.87e-03
11009Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485ECGA0004853.86e-03
11010aparc-pial rh area lingualGCST900031863.82e-03
11011Other anxiety disordersFING000009603.81e-03
11012Main speciality of consultant (recoded) - Anaesthetics | Summary AdministrationUKBB000004133.81e-03
11013T1 CAT volume R CrusIGCST903841203.80e-03
11014IMPA1 levelsGCST904696103.80e-03
11015CELA3A levelsGCST904687023.77e-03
11016DTI autoptx L2 ptr r tractGCST903851863.75e-03
11017Tiglylcarnitine (C5:1-DC) levelsGCST901998003.75e-03
11018Estimated glomerular filtration rate (creatinine)GCST904284473.75e-03
11019NOS1 levelsGCST904700623.73e-03
11020IDP dMRI ProbtrackX ISOVF slf rGCST900045473.72e-03
11021CDK8_CCNC levelsGCST902408253.72e-03
11022Prostate cancerGCST900118083.71e-03
11023Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T11ECGU0000113.70e-03
11024Overall health rating | General healthUKBB000006213.69e-03
11025Eye problems/disorders - Cataract | EyesightUKBB000002303.68e-03
11026Types of transport used (excluding work) - Cycle | Physical activityUKBB000008773.66e-03
11027Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB000007183.65e-03
11028IDP dMRI TBSS OD Anterior limb of internal capsule LGCST900044193.65e-03
11029MNDA levelsGCST904699273.65e-03
11030Arm predicted mass (left) | Impedance measuresUKBB000000493.64e-03
11031Ischemic strokeGCST900186443.64e-03
11032Sphingomyelin_33:1_[M+H]1+ levelsGCST900602293.63e-03
11033DTI TBSS MO Medial lemniscus LGCST903846293.63e-03
11034Mean corpuscular volume (UKB data field 30040)GCST904680863.62e-03
11035DLL1 levelsGCST904690043.62e-03
11036Congenital malformations of heart and great arteriesFING000003363.62e-03
11037Red blood cell erythrocyte count (UKB data field 30010)GCST904680983.60e-03
11038Impedance of whole body | Impedance measuresUKBB000003603.59e-03
11039Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary AdministrationUKBB000004663.58e-03
11040HSIL lesion of the cervix uteriFING000006243.57e-03
11041LTBR/SIRPB1 ratioGCST903153393.57e-03
11042Main speciality of consultant (recoded) - General medicine | Summary AdministrationUKBB000004163.56e-03
11043SLC4A1 levelsGCST904706633.55e-03
11044HippSubfield lh volume subiculum-bodyGCST900026693.55e-03
11045Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488ECGA0004883.53e-03
11046Temporomandibular joint disorders, including avohilmoFING000013553.52e-03
11047T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128)GCST903209473.51e-03
11048BA-exvivo rh area entorhinalGCST900032343.50e-03
11049DTI TBSS FA Corticospinal tract RGCST903843863.47e-03
11050Osteochondrodysplasia with defects of growth of tubular bones and spineFING000009103.46e-03
11051Viral hepatitis (PheCode 70)GCST904755523.45e-03
11052IGFBP4 levelsGCST904695303.45e-03
11053Other alveolar and parietoalveolar pneumonopathy (PheCode 504)GCST904760333.44e-03
11054X-24328 levelsGCST902006243.39e-03
11055Neurofibromatosis, type 2FING000008673.39e-03
11056Colorectal cancer, excluding all cancers (controls excluding all cancers)FING000003173.38e-03
11057T1 FreeSurfer DKT lh precentral thicknessGCST903842463.38e-03
11058KIF22 levelsGCST904696823.37e-03
11059RSPO1/RSPO3 ratioGCST903157903.36e-03
11060IDP dMRI ProbtrackX FA atr lGCST900039273.35e-03
11061ESAM/PDGFB ratioGCST903147143.35e-03
11062Impedance of arm right (UKB data field 23109)GCST904681723.31e-03
11063Myocardial infarction | circulatory systemUKBB000004913.29e-03
11064SPINT1/SUSD2 ratioGCST903158783.27e-03
11065PACS2 levelsGCST904701413.27e-03
11066Dupuytren's diseaseGCST903012523.24e-03
11067Vascular/heart problems diagnosed by doctor - Angina | Medical conditionsUKBB000008963.24e-03
11068ENPP7 levelsGCST904691183.24e-03
11069aparc-DKTatlas rh area lingualGCST900032763.23e-03
11070IDP dMRI TBSS OD Posterior limb of internal capsule RGCST900044203.22e-03
11071Volume of left anterior amygdaloid areaGCST904749343.21e-03
11072Obesity related asthmaFING000008973.20e-03
11073Number of non-cancer illnesses (weighted GWA)GCST902672913.20e-03
11074Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB000007193.19e-03
11075Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T499ECGU0004993.19e-03
11076Congenital lactase deficiencyFING000003293.19e-03
11077CDH5/LGALS4 ratioGCST903139563.19e-03
11078Age when finished full-time education (weighted GWA)GCST902672813.18e-03
11079Morning/evening person (chronotype) | SleepUKBB000004833.17e-03
11080Paroxysmal tachycardiaFING000011513.17e-03
11081TPPP3 levelsGCST904709483.17e-03
11082Retinal thickness (functional principal component 2)GCST904557223.16e-03
11083CXCL5/SERPINE1 ratioGCST903143543.14e-03
11084Polycystic ovarian syndromeFING000011823.13e-03
11085aparc-DKTatlas rh volume lateraloccipitalGCST900029023.12e-03
11086TNFRSF11B levelsGCST902431583.11e-03
11087Foveal thicknessGCST906241133.08e-03
11088Lysophosphatidylcholine (26:0) [sn1] levelsGCST900241883.07e-03
11089GABBR2 levelsGCST902412303.07e-03
11090aparc-pial rh area caudalmiddlefrontalGCST900031773.07e-03
11091Radial peak diastolic strain rateGCST900190143.05e-03
110924-acetamidobutanoate levelsGCST902434403.04e-03
11093Total lipids in very small VLDLGCST905008103.01e-03
11094IDP dMRI ProbtrackX ISOVF fmaGCST900045353.01e-03
11095Time spent outdoors in winter | Sun exposureUKBB000008193.01e-03
11096Diastolic blood pressureGCST904727783.00e-03
11097CLK2 levelsGCST902409752.99e-03
11098Volume of left paralaminar nucleusGCST904748952.95e-03
11099Current SmokerFING000003712.94e-03
11100Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T192ECGA0001922.93e-03
11101IDP dMRI TBSS L1 Cerebral peduncle LGCST900040902.93e-03
11102Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T449ECGU0004492.89e-03
11103Urate levels (UKB data field 30880)GCST904681072.88e-03
11104Diverticular disease of intestineFING000004712.88e-03
11105Chromatiales abundance in stoolGCST900323182.87e-03
11106RUVBL1 levelsGCST904705092.87e-03
11107Fruit intake (standard GWA)GCST902672822.86e-03
11108EPHB4/ESAM ratioGCST903146792.86e-03
11109ICD10 O14: Pre-eclampsiaGCST904542332.85e-03
11110Nonalcoholic steatohepatitisFING000008792.83e-03
11111DTI TBSS L3 Retrolenticular part of internal capsule RGCST903845442.82e-03
11112ICD10 C53: Malignant neoplasm of cervix uteriGCST904542022.82e-03
11113CAG-269 sp001915995 abundance in stoolGCST900322662.81e-03
11114IDP dMRI TBSS L2 Superior fronto-occipital fasciculus LGCST900041662.81e-03
11115BAIAP2/MME ratioGCST903134532.81e-03
11116aparc-a2009s lh volume G-precentralGCST900029532.79e-03
11117Volume of right basal nucleusGCST904750152.79e-03
11118CCS levelsGCST904685942.79e-03
11119Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T500ECGU0005002.79e-03
11120Diverticulosis (PheCode 562.1)GCST904760762.78e-03
11121wg rh intensity-contrast pericalcarineGCST900038472.78e-03
11122aparc-Desikan rh area lingualGCST900031192.78e-03
11123GIPC2 levelsGCST904693472.77e-03
11124CoxarthrosisFING000003622.76e-03
11125aparc-a2009s rh area Pole-occipitalGCST900034122.76e-03
11126PDCD5 levelsGCST904701822.76e-03
11127IDP dMRI TBSS MD Superior cerebellar peduncle RGCST900040392.75e-03
11128PIKFYVE levelsGCST904702352.74e-03
11129BSG levelsGCST904684722.72e-03
11130Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490ECGA0004902.71e-03
11131Number of incorrect matches in round | Pairs matchingUKBB000005382.71e-03
11132CPB1/REG1B ratioGCST903142132.71e-03
11133Triacylglycerol_49:3_[M+NH4]1+ levelsGCST900604432.70e-03
11134Autorefraction - 6mm strong meridian (right) | EyesightUKBB000000762.70e-03
11135T1 FreeSurfer aseg Right-PutamenGCST903841632.69e-03
11136SCARA5/TNC ratioGCST903158102.69e-03
11137Gestational age at birth (child effect)GCST902684212.69e-03
11138Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T22ECGA0000222.68e-03
11139wg lh intensity-contrast inferiorparietalGCST900037992.68e-03
11140CNTN4 levelsGCST902407862.66e-03
11141SCRG1 levelsGCST904705542.66e-03
11142BA-exvivo lh area BA1GCST900032072.65e-03
11143Glycine levelsGCST902435812.65e-03
11144CRKL/PLA2G4A ratioGCST903142712.64e-03
11145Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST900418372.64e-03
11146ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cystGCST904542152.64e-03
11147T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41)GCST903206042.62e-03
11148Heart rate variability traits (SDNN)GCST0047342.59e-03
11149T1 FreeSurfer aseg Left-PallidumGCST903841462.57e-03
11150VEGFA levelsGCST900119952.57e-03
11151DTI TBSS FA Sagittal stratum RGCST903844102.57e-03
11152RGMB levelsGCST904704642.56e-03
11153IDP T1 FIRST left hippocampus volumeGCST900024442.55e-03
11154TEK levelsGCST900120132.55e-03
11155RILPL2 levelsGCST904704702.53e-03
11156aparc-pial rh area lateralorbitofrontalGCST900031852.53e-03
11157PPP2R2A levelsGCST906181222.51e-03
11158T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118)GCST903209372.50e-03
11159Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181ECGU0001812.50e-03
11160IDP T1 FAST ROIs V cerebellum VIGCST900025672.50e-03
11161FUT8/SPARC ratioGCST903148932.49e-03
11162PER3 levelsGCST904702102.47e-03
11163SCGN levelsGCST904705442.47e-03
11164aparc-DKTatlas rh volume parstriangularisGCST900029112.46e-03
11165Retinal detachments and breaksFING000012602.46e-03
11166Brussel sprout likingGCST900947142.45e-03
11167Homeostasis model assessment of beta-cell functionGCST0051802.45e-03
11168MED18/ZBTB16 ratioGCST903154162.44e-03
11169DNPH1/NSFL1C ratioGCST903145262.43e-03
11170Diseases of esophagus (PheCode 530)GCST904760452.43e-03
11171IDP dMRI TBSS L3 Uncinate fasciculus RGCST900042152.41e-03
11172LRRC37A2 levelsGCST904698022.39e-03
11173IDP dMRI TBSS MD Anterior limb of internal capsule RGCST900040432.39e-03
11174Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levelsGCST900251152.38e-03
11175CTRB1/PLA2G1B ratioGCST903143072.38e-03
11176ACAA1 levelsGCST904681932.37e-03
11177Tibia length to body height ratioGCST902702582.37e-03
11178Pulse pressure, automated reading | Cardiovascular measurementUKBB000007142.36e-03
11179Childhood asthma (age<16) (more control exclusions)FING000002702.36e-03
11180Mean reticulocyte volume (UKB data field 30260)GCST904680882.36e-03
11181Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000007202.35e-03
11182Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivityGCST903027192.35e-03
11183Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004282.35e-03
11184Impedance of whole body (UKB data field 23106)GCST904681732.35e-03
11185Pulse pressure, automated reading | Cardiovascular measurementUKBB000007152.35e-03
11186T1 FreeSurfer DK lh lateraloccipital areaGCST903855982.33e-03
11187Breast cancerGCST900118042.33e-03
11188X-17357 levelsGCST902005502.31e-03
11189HealthspanGCST0074062.31e-03
11190aparc-a2009s rh area S-subparietalGCST900034412.30e-03
11191Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)FING000003162.30e-03
11192RAD23B levelsGCST904704182.30e-03
11193Coagulation defects (PheCode 286)GCST904757962.28e-03
11194Phosphatidylcholine diacyl C38:4 levelsGCST902400462.27e-03
11195Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T33ECGA0000332.27e-03
11196Alanine levelsGCST904970852.26e-03
11197aparc-pial rh area TotalSurfaceGCST900031742.25e-03
11198Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T49ECGU0000492.24e-03
11199Chicken likingGCST900947322.22e-03
11200Lower back pain or/and sciaticaFING000007312.22e-03
11201Chained arithmetic | Fluid intelligence / reasoningUKBB000001262.22e-03
11202PAPL levelsGCST904272082.21e-03
11203Torso length to body height ratioGCST902702622.21e-03
11204aparc-Desikan rh area supramarginalGCST900031372.20e-03
11205Secondary diabetes mellitus (PheCode 249)GCST904756552.20e-03
11206NMNAT1 levelsGCST904700572.20e-03
11207Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T191ECGA0001912.20e-03
11208Other dorsopathies, not elsewhere classifiedFING000010412.20e-03
11209FCN1 levelsGCST906185652.19e-03
11210Autorefraction - 6mm strong meridian angle (left) | EyesightUKBB000000772.18e-03
11211Other aneurysm (PheCode 442)GCST904759922.18e-03
11212PADI4 levelsGCST904701432.18e-03
11213Operation code - pilonidal sinus surgery (anal) | OperationsUKBB000005632.17e-03
11214Comparative height size at age 10 | Early life factorsUKBB000001432.16e-03
11215Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T10ECGU0000102.15e-03
11216Type 2 diabetesGCST0101182.13e-03
11217HippSubfield lh volume Whole-hippocampusGCST900026892.13e-03
11218Shoulder width to body height ratioGCST902702612.12e-03
11219DTI TBSS MD Superior fronto-occipital fasciculus LGCST903846152.12e-03
11220Triglyceride to HDL cholesterol ratioGCST902959532.10e-03
11221aparc-a2009s rh volume G-front-inf-TriangulGCST900030122.10e-03
11222Right-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivityGCST903027802.09e-03
11223aparc-Desikan lh thickness GlobalMeanThicknessGCST900034452.09e-03
11224Disorders of the thyroid glandFING000004632.09e-03
11225T1 FreeSurfer DK rh MeanThickness thicknessGCST903857572.06e-03
11226Bicarbonate (minimum, inv-norm transformed)GCST904751502.05e-03
11227AXIN1/BACH1 ratioGCST903134002.05e-03
11228Arm fat-free mass (left) | Impedance measuresUKBB000000472.05e-03
11229Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000007212.03e-03
11230T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 98)GCST903206612.02e-03
11231Qualifications - NVQ or HND or HNC or equivalent | EducationUKBB000007302.02e-03
11232T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 95)GCST903206582.01e-03
11233DermatitisFING000004012.01e-03
11234SPESP1 levelsGCST904707202.01e-03
11235Renal tubulo-interstitial diseasesFING000012512.01e-03
11236FEV1 FVC ratio Z score (UKB data field 20258)GCST904681652.00e-03
11237PDP1 levelsGCST904242961.99e-03
11238Pulmonary embolismGCST904681481.99e-03
11239Iron deficiency anemia secondary to blood loss (chronic) (PheCode 280.2)GCST904757701.99e-03
11240Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477ECGU0004771.99e-03
11241T1 FreeSurfer aseg MaskVol-to-eTIVGCST903841921.98e-03
11242Coxarthrosis, primaryFING000003631.98e-03
11243IDP T1 FAST ROIs L intracalc cortexGCST900024971.98e-03
11244Getting up in morning | SleepUKBB000002851.98e-03
11245Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T447ECGU0004471.97e-03
11246Glaucoma (multi-trait analysis)GCST0097221.97e-03
11247Prescriptions - latanoprost | prostaglandin analogUKBB000006861.95e-03
11248Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T443ECGU0004431.94e-03
11249STX6 levelsGCST904707741.94e-03
11250Right-hemisphere somatomotor network to thalamus white-matter structural connectivityGCST903027941.94e-03
11251PMVK/PRTFDC1 ratioGCST903156951.94e-03
11252Right ventricular end systolic volumeGCST902681181.93e-03
11253GERD (PheCode 530.11)GCST904760471.92e-03
11254Intra-ocular pressure, corneal-compensated (left) | Intraocular pressureUKBB000003741.92e-03
11255Autorefraction - 3mm cylindrical power angle (left) | EyesightUKBB000000641.92e-03
11256Acquired deformities of fingers and toes | Other joint disordersUKBB000000061.92e-03
11257Sequelae of cerebrovascular diseaseFING000012941.91e-03
11258Left-hemisphere salience/ventral attention network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027131.91e-03
11259Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney diseaseGCST902646741.90e-03
11260Hip fractureGCST901612401.90e-03
11261Trunk fat-free mass | Impedance measuresUKBB000008651.89e-03
11262HeightGCST902786371.88e-03
11263IDP dMRI ProbtrackX FA unc rGCST900039511.88e-03
11264IDP dMRI TBSS L1 Superior fronto-occipital fasciculus RGCST900041171.86e-03
11265Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171ECGA0001711.86e-03
11266Other peripheral vertigoFING000010881.85e-03
11267aparc-Desikan lh area fusiformGCST900030791.85e-03
11268T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108)GCST903209271.85e-03
11269Pain in jointFING000011371.84e-03
11270Pyruvate levels (UKB data field 23472)GCST902695691.84e-03
11271SEPHS1 levelsGCST902427401.83e-03
11272MAP3K5/ZBTB16 ratioGCST903153801.83e-03
11273Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000007161.82e-03
11274IDP dMRI TBSS MD Uncinate fasciculus RGCST900040711.82e-03
11275Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57)GCST906687351.80e-03
11276Sleep apneaGCST904758241.80e-03
11277CTRC/KIRREL2 ratioGCST903143091.79e-03
11278WFIKKN1 levelsGCST904710761.79e-03
11279IDP dMRI ProbtrackX L1 cgh lGCST900042521.79e-03
11280aparc-a2009s rh volume S-calcarineGCST900030421.79e-03
11281Height, inverse-rank normalizedFING000006071.78e-03
11282N-acetyltaurine levelsGCST901999671.78e-03
11283aparc-DKTatlas rh volume parahippocampalGCST900029071.76e-03
11284CKAP4/LTBR ratioGCST903140741.76e-03
11285DTI TBSS L2 Anterior corona radiata LGCST903844991.76e-03
11286DSG4 levelsGCST904690441.75e-03
11287CystitisFING000003761.74e-03
11288Left-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903027501.74e-03
11289Mean reticulocyte volumeGCST900023961.72e-03
11290IDP T1 FAST ROIs L occ poleGCST900025451.71e-03
11291Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T203ECGA0002031.71e-03
11292Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levelsGCST902000131.71e-03
11293Diastolic blood pressureGCST903016991.71e-03
11294Pregnenetriol sulfate levelsGCST902002411.70e-03
11295Lysophosphatidylcholine (22:0) [sn2] levelsGCST900241761.70e-03
11296Postinflammatory pulmonary fibrosis (PheCode 502)GCST904760321.69e-03
11297rfMRI connectivity (ICA100 edge 659)GCST900055121.68e-03
11298Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T169ECGA0001691.68e-03
11299Glomerular disorders in diseases classified elsewhereFING000005821.68e-03
11300Appendicular lean massGCST900000261.66e-03
11301aparc-Desikan rh area caudalmiddlefrontalGCST900031101.65e-03
11302Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T48ECGU0000481.65e-03
11303Staphylococcus A fleurettii abundance in stoolGCST900325641.65e-03
11304IDP dMRI TBSS L1 Anterior limb of internal capsule RGCST900040911.64e-03
11305IDP T1 FAST ROIs L precentral gyrusGCST900024631.64e-03
11306AcneFING000000101.64e-03
11307Perforation of tympanic membraneFING000011551.64e-03
11308Autorefraction - 3mm weak meridian (left) | EyesightUKBB000000691.64e-03
11309PIK3IP1 levelsGCST904702341.63e-03
11310IDP dMRI TBSS L2 Anterior limb of internal capsule RGCST900041391.63e-03
11311Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496ECGU0004961.62e-03
11312OsteoarthritisGCST904681441.62e-03
11313CA1/TGM2 ratioGCST903135751.62e-03
11314Autorefraction - 3mm strong meridian (right) | EyesightUKBB000000661.62e-03
11315Ascending aorta diameterGCST902673901.61e-03
11316DTI TBSS FA Anterior corona radiata LGCST903844031.61e-03
11317Hyperplasia of prostate (PheCode 600)GCST904761531.60e-03
11318GGT1/MME ratioGCST903149301.59e-03
11319Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T497ECGA0004971.59e-03
11320Autorefraction - 3mm weak meridian (right) | EyesightUKBB000000701.59e-03
11321T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63)GCST903208821.57e-03
11322Colorectal cancer (PheCode 153)GCST0083721.57e-03
11323CDSN/WFDC12 ratioGCST903139991.57e-03
11324Non-cancer illness code, self-reported - angina | Medical conditionsUKBB000005051.55e-03
11325rfMRI connectivity (ICA100 edge 1066)GCST900059191.55e-03
11326Autorefraction - 3mm cylindrical power (right) | EyesightUKBB000000631.55e-03
11327Benign neoplasm: salivary glands, exclude unknown (D119)FING000001991.54e-03
11328Congenital malformations of the circulatory systemFING000003401.53e-03
11329Right-hemisphere salience/ventral attention network to thalamus white-matter structural connectivityGCST903028171.53e-03
11330Multiple system atrophyGCST904069251.53e-03
11331Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T178ECGU0001781.52e-03
11332IDP dMRI TBSS L2 External capsule LGCST900041561.52e-03
11333Non-insulin-dependent diabetes mellitus | Diabetes mellitusUKBB000005241.52e-03
11334Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000007171.51e-03
11335LCN15 levelsGCST904697461.51e-03
11336Varicose veinsFING000014161.50e-03
11337Trunk fat percentage | Impedance measuresUKBB000008641.50e-03
11338Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T202ECGA0002021.50e-03
11339DTI TBSS FA Retrolenticular part of internal capsule RGCST903844001.49e-03
11340Volume of left accessory basal nucleusGCST904749401.49e-03
11341Optic cup areaGCST0041371.49e-03
11342Arm fat-free mass (right) | Impedance measuresUKBB000000481.49e-03
11343Trunk predicted mass | Impedance measuresUKBB000008661.48e-03
11344Non-oily fish consumptionGCST901329941.47e-03
11345DOK1 levelsGCST904690281.47e-03
11346aparc-a2009s rh volume G-precentralGCST900030271.46e-03
11347DTI autoptx L1 slf l tractGCST903851601.45e-03
11348BA-exvivo rh thickness V1GCST900035361.45e-03
11349Serine levelsGCST902004151.44e-03
11350Alcohol consumption (drinks per month) (UKB data field 1578, 4424)GCST901329921.43e-03
11351aparc-a2009s lh area G-postcentralGCST900033241.42e-03
11352Red blood cell (erythrocyte) count | Blood countUKBB000007471.42e-03
11353Urine 3-hydroxyindolin-2-one sulfate levels in chronic kidney diseaseGCST902645081.42e-03
11354Leisure/social activities - Adult education class | Social supportUKBB000003981.42e-03
11355DTI TBSS L1 Superior longitudinal fasciculus LGCST903844691.41e-03
11356HAVCR1 levelsGCST900120411.41e-03
11357aparc-DKTatlas rh area caudalmiddlefrontalGCST900032671.40e-03
11358aseg lh volume Accumbens-areaGCST900026261.39e-03
11359Bread intake (UKB data field 1438)GCST904681621.39e-03
11360Forced vital capacity FVC Z score (UKB data field 20257)GCST904681671.39e-03
11361Anal and rectal conditions | digestiveUKBB000000291.39e-03
11362Arm predicted mass (right) | Impedance measuresUKBB000000501.37e-03
11363Autorefraction - 6mm weak meridian (right) | EyesightUKBB000000801.37e-03
11364IDP dMRI TBSS L2 Uncinate fasciculus LGCST900041681.37e-03
11365Estrone 3-sulfate metabolite levelGCST906163831.35e-03
11366GKN2 levelsGCST900894131.35e-03
11367Autorefraction - 3mm strong meridian (left) | EyesightUKBB000000651.34e-03
11368Gamma glutamyl transpeptidaseGCST900187341.34e-03
11369CTSE levelsGCST904689111.34e-03
11370Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T257ECGA0002571.34e-03
11371Type 2 diabetes, definitions combinedFING000013821.33e-03
11372FABP1/LGALS4 ratioGCST903147521.32e-03
11373aparc-Desikan rh thickness postcentralGCST900035001.30e-03
11374Exposure to tobacco smoke at home | SmokingUKBB000002281.30e-03
11375Eye problems/disorders - Glaucoma | EyesightUKBB000002311.29e-03
11376Ascending aorta diameterGCST900910501.29e-03
11377X-24947 levelsGCST902006511.29e-03
11378DTI TBSS L1 External capsule LGCST903844611.27e-03
11379aparc-a2009s lh area G-oc-temp-med-LingualGCST900033181.26e-03
11380CD160 levelsGCST904685991.25e-03
11381Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T167ECGA0001671.25e-03
11382N-acetylalanine levelsGCST902003031.25e-03
11383aparc-Desikan rh thickness paracentralGCST900034951.25e-03
11384Forced expiratory volume in 1-second (FEV1), predicted | SpirometryUKBB000002521.24e-03
11385Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3ECGA0000031.24e-03
11386Type 2 diabetes | endocrine/metabolicUKBB000008671.23e-03
11387aseg rh volume CaudateGCST900026381.22e-03
11388HDLBP levelsGCST900875331.22e-03
11389Treatment or medication use - metformin (UKB data field 20003_1140884600)GCST900422451.22e-03
11390Moderate to vigorous physical activity levelsGCST0060971.22e-03
11391X-18601 levelsGCST902435011.22e-03
11392aparc-a2009s rh area S-collat-transv-antGCST900034201.21e-03
11393GGT1 levelsGCST904693361.20e-03
11394IDP T1 FAST ROIs R temporal poleGCST900024661.20e-03
11395COL24A1 levelsGCST904688141.20e-03
11396Esophagitis, GERD and related diseases (PheCode 530.1)GCST904760461.20e-03
11397Takes medication for Sleep apnea?GCST904752581.20e-03
11398Pyruvate levelsGCST900929421.19e-03
11399Creatinine levelsGCST902786241.18e-03
11400Obesity (PheCode 278.1)GCST904757621.18e-03
11401Uterine leiomyomataGCST902398561.18e-03
11402TGFBR2 levelsGCST904708471.17e-03
11403Principal component-derived dietary pattern 9GCST901330141.16e-03
11404Other arrhythmiasFING000009621.16e-03
11405T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2)GCST903205651.16e-03
11406TGFBR2/TNFRSF19 ratioGCST903159171.16e-03
11407HippSubfield lh volume CA4-bodyGCST900026831.16e-03
11408Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906685241.14e-03
11409Estimated glomerular filtration rate, cystain C | Other measurementUKBB000002101.14e-03
11410Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82)GCST906685261.14e-03
11411CDH5/ENG ratioGCST903139541.13e-03
11412Mean volume of bilateral amygdalaGCST904749941.13e-03
11413rfMRI connectivity ICA-features 6GCST900063441.13e-03
11414CD79B levelsGCST904686481.12e-03
11415Fasting blood glucoseGCST0051861.11e-03
11416NCR3 levelsGCST900881791.11e-03
11417Operation code - haemorroidectomy / piles surgery/ banding of piles | OperationsUKBB000005571.11e-03
11418Autorefraction - 3mm weak meridian angle (left) | EyesightUKBB000000711.11e-03
11419Acute upper respiratory infections of multiple and unspecified sitesFING000000351.10e-03
11420Methods of admission to hospital (recoded) - Elective admission: Waiting List | Summary AdministrationUKBB000004631.09e-03
11421IDP dMRI TBSS MD Anterior limb of internal capsule LGCST900040441.09e-03
11422Volume of right basal nucleusGCST904749101.09e-03
11423Total cholesterol levels in small LDLGCST901326901.08e-03
11424Serum 25-Hydroxyvitamin D level varianceGCST900006211.08e-03
11425HippSubfield lh volume CA3-bodyGCST900026801.07e-03
11426Autorefraction - 6mm weak meridian (left) | EyesightUKBB000000791.06e-03
11427Inguinal hernia | HerniaUKBB000003631.06e-03
11428Diabetes, insulin treatment (Kela reimbursement) (more control exclusions)FING000004101.05e-03
11429Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T32ECGA0000321.05e-03
11430Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170ECGA0001701.04e-03
11431Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T258ECGA0002581.04e-03
11432Senile cataractFING000012901.03e-03
11433Left bundle-branch blockFING000007161.02e-03
11434Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027611.01e-03
11435Left-hemisphere limbic network to thalamus white-matter structural connectivityGCST903027361.01e-03
11436aparc-Desikan rh volume precentralGCST900028241.01e-03
11437GUCA2A levelsGCST904694181.00e-03
11438SMAD2 levelsGCST904706761.00e-03
11439SERPINA5 levelsGCST904705859.99e-04
11440CSF2RB levelsGCST904688839.96e-04
11441Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180ECGU0001809.96e-04
11442Obstructive sleep apnea (PheCode 327.32)GCST904758259.88e-04
11443Leisure/social activities - None of the above | Social supportUKBB000003999.86e-04
11444ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrheaGCST904542199.86e-04
11445HLA-E levelsGCST904694599.81e-04
11446Episodal and paroxysmal disordersFING000005149.81e-04
11447Hyperplasia of prostateFING000006359.76e-04
11448IDP dMRI TBSS ISOVF Posterior corona radiata LGCST900045049.73e-04
11449BA-exvivo lh volume BA1GCST900028359.68e-04
11450Mean corpuscular hemoglobin varianceGCST905656939.67e-04
11451SLURP1 levelsGCST904706749.67e-04
11452Frequency of stair climbing in last 4 weeks | Physical activityUKBB000002669.64e-04
11453Acute tubulo-interstitial nephritisFING000000339.64e-04
11454Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168ECGA0001689.63e-04
11455IDP dMRI TBSS L2 Middle cerebellar peduncleGCST900041239.61e-04
11456Volume of left anterior amygdaloid areaGCST904748719.59e-04
11457PRSS2 levelsGCST902431269.56e-04
11458Prescriptions - bisoprolol | selective beta1 antagonist,beta blockerUKBB000006729.48e-04
11459KYAT1 levelsGCST904697219.45e-04
11460DTI autoptx MD str r tractGCST903852449.45e-04
11461Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T214ECGU0002149.42e-04
11462Pulse pressureGCST903017019.40e-04
114633-methyl-2-oxovalerate levelsGCST902434859.34e-04
11464Bicuspidal aortic valve syndromeFING000002129.33e-04
11465Special factor anxiety/tension in mitochondrial haplogroup UGCST902641279.20e-04
11466LYPD8 levelsGCST904698299.17e-04
11467Dihexosylceramide (d18:1/22:0) levelsGCST900253489.17e-04
11468Basal metabolic rate | Impedance measuresUKBB000000869.06e-04
11469IDP dMRI ProbtrackX OD str rGCST900044749.05e-04
11470Concentration of very small VLDL particlesGCST905008199.05e-04
11471Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T465ECGU0004658.99e-04
11472Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48ECGA0000488.93e-04
11473DTI TBSS MD Anterior limb of internal capsule LGCST903845898.86e-04
11474Autorefraction - 6mm strong meridian (left) | EyesightUKBB000000758.85e-04
11475TRIM40 levelsGCST904709688.84e-04
11476Valine levelsGCST901327528.71e-04
11477T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 23)GCST903208428.69e-04
11478Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49ECGA0000498.66e-04
11479Volume of left cortico-amygdaloid transition areaGCST904748808.56e-04
11480IDP T1 FAST ROIs R precentral gyrusGCST900024648.52e-04
11481NTF4 levelsGCST904700958.50e-04
11482ECHDC3 levelsGCST904690628.49e-04
11483Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)FING000000418.41e-04
11484aparc-DKTatlas rh area supramarginalGCST900032948.40e-04
11485Age at first sexual intercourseGCST900000478.39e-04
11486Occupational creativityGCST903087748.34e-04
11487Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)FING000007518.33e-04
11488Cholesteryl Esters to Total Lipids in Medium VLDL percentageGCST904989448.33e-04
11489Body mass indexGCST904466458.32e-04
11490Physical function (baseline)GCST905658378.28e-04
11491Melanoma in situ (controls excluding all cancers)FING000008038.27e-04
11492Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9ECGU0000098.24e-04
11493Height (baseline)GCST905658438.24e-04
11494Whole body fat mass | Impedance measuresUKBB000009148.18e-04
11495Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027158.16e-04
11496Acquired foot deformities | musculoskeletalUKBB000000078.10e-04
11497Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T491ECGA0004918.06e-04
11498Age when finished full-time education (standard GWA)GCST902672808.05e-04
11499Volume of right lateral nucleusGCST904749228.03e-04
11500Alcohol drinker status: current or former vs never (UKB data field 20117)GCST901329238.03e-04
11501Other dyspnea (PheCode 512.9)GCST904760427.99e-04
11502BCR/CLIP2 ratioGCST903134867.97e-04
11503Time spent watching television (TV) | Physical activityUKBB000008217.95e-04
11504CholecystitisFING000002747.87e-04
11505CRISP2 levelsGCST904688657.82e-04
11506Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T204ECGA0002047.76e-04
11507Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T448ECGU0004487.74e-04
11508Macular puckering of retina (PheCode 362.26)GCST904758547.71e-04
11509Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T462ECGU0004627.71e-04
11510Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney diseaseGCST902660167.70e-04
11511Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivityGCST903026937.67e-04
11512CD27/DLL1 ratioGCST903137717.67e-04
11513Ceramide (d16:1/24:0) levelsGCST900240277.67e-04
11514HeightGCST903028907.63e-04
11515Ankle spacing width | Bone-densitometry of heelUKBB000000357.61e-04
11516CLPP/DECR1 ratioGCST903141377.60e-04
11517Right-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivityGCST903028047.58e-04
11518T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11)GCST903205747.53e-04
11519X-16087 levelsGCST902005377.52e-04
11520DECR1/METAP1D ratioGCST903144487.46e-04
11521Volume of left cortical nucleusGCST904749647.40e-04
11522aseg global volume 3rd-VentricleGCST900025997.37e-04
11523Insomnia complaintsGCST0064877.35e-04
11524Spherical power (left) | AutorefractionUKBB000007907.34e-04
11525Non-cancer illness year/age first occurred | Medical conditionsUKBB000005237.32e-04
11526CTRB1/KIRREL2 ratioGCST903143067.31e-04
11527CRACR2A/IRAG2 ratioGCST903142277.30e-04
11528Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T446ECGU0004467.28e-04
11529Gastrointestinal issues (confirmatory factor analysis Factor 31)GCST903093657.26e-04
11530Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34ECGA0000347.26e-04
11531Lysophosphatidylcholine (26:0) [sn2] levelsGCST900241897.24e-04
11532Diseases of male genital organsFING000004267.23e-04
11533Retinal thickness (functional principal component 1)GCST904557217.22e-04
11534Impedance of leg (right) | Impedance measuresUKBB000003597.18e-04
11535Benign neoplasm: Parotid glandFING000001927.10e-04
11536Free Cholesterol to Total Lipids in Small LDL percentageGCST904996377.09e-04
11537FOLH1 levelsGCST904256617.03e-04
11538Body size (confirmatory factor analysis Factor 21)GCST903093557.02e-04
11539aparc-DKTatlas rh volume cuneusGCST900028967.00e-04
11540Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027626.97e-04
11541Chronic ulcer of skin, not elsewhere classifiedFING000003006.96e-04
11542RGCC levelsGCST904704616.90e-04
11543Total cholesterol minus HDL-C levelsGCST904991306.87e-04
11544ATXN10/CASP10 ratioGCST903133966.85e-04
11545Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487ECGA0004876.84e-04
11546CDHR2 levelsGCST904686796.82e-04
11547HematocritGCST902786346.81e-04
11548EndometriosisGCST900186196.78e-04
11549PRR15 levelsGCST904247906.75e-04
11550Psoriatic arthritisGCST902439566.71e-04
11551Phosphatidylcholine diacyl C38:3 levelsGCST902400456.61e-04
11552aseg lh intensity VentralDCGCST900037756.58e-04
11553YBX1 levelsGCST900907996.56e-04
11554Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26ECGA0000266.54e-04
11555Bread type: Wholemeal or wholegrain (UKB data field 1448_3)GCST901329666.53e-04
11556Orotidine levelsGCST902006816.53e-04
11557Sleep related movement disorders (PheCode 327.7)GCST904758276.52e-04
11558Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177ECGU0001776.48e-04
11559N-acetylmethionine levelsGCST902002896.45e-04
11560Iliac isthmus breadthGCST904489076.44e-04
11561Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20ECGA0000206.44e-04
11562Pelvic heightGCST904489126.44e-04
11563Ovarian cancer-related tumor marker CA 125 levelsGCST900120786.44e-04
11564IDP dMRI ProbtrackX MD fmaGCST900042296.43e-04
11565Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivityGCST903028166.41e-04
11566CC2D1A/WWP2 ratioGCST903136686.36e-04
11567Diabetes mellitus | endocrine/metabolicUKBB000001696.20e-04
11568Disorders of other endocrine glandsFING000004506.12e-04
11569T1 FIRST volume L PutaGCST903839876.11e-04
11570MYOC levelsGCST904228256.09e-04
11571Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21ECGA0000216.08e-04
11572N-acetyl-2-aminoadipate levelsGCST902002686.04e-04
11573Inguinal hernia | digestiveUKBB000003626.04e-04
11574Urinary calculus | genitourinaryUKBB000008866.03e-04
11575Illnesses of father - Diabetes | Family historyUKBB000003416.03e-04
11576ThalamNuclei lh volume CeMGCST900027256.00e-04
11577Other extrapyramidal and movement disorders in other diseasesFING000010475.99e-04
11578Family history of certain disabilities and chronic diseases leading to disablement | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000002365.99e-04
11579Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T38ECGA0000385.99e-04
11580Leisure screen timeGCST901043395.98e-04
11581N-acetyl-1-methylhistidine levelsGCST902006905.93e-04
11582AnginaGCST904681095.92e-04
11583Alcohol drinker status - Never | AlcoholUKBB000000225.92e-04
11584Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T495ECGA0004955.87e-04
11585Other arthropathies | musculoskeletalUKBB000006015.85e-04
11586Blood urea nitrogen levelsGCST900187285.83e-04
11587Operative procedures - Palmar fasciectomy | Summary OperationsUKBB000005865.76e-04
11588Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179ECGU0001795.74e-04
11589AsthmaGCST900860475.73e-04
11590Intra-ocular pressure, corneal-compensated (right) | Intraocular pressureUKBB000003755.73e-04
11591SpondylopathiesFING000013255.71e-04
11592aparc-a2009s lh thickness Pole-occipitalGCST900036445.65e-04
11593Sodium in urine | Urine assaysUKBB000007855.58e-04
11594Peak expiratory flow (PEF) | SpirometryUKBB000006385.55e-04
11595Fresh fruit intake | DietUKBB000002725.53e-04
11596HSIL lesion of the cervix uteri, vagina or vulvaFING000006255.49e-04
11597SFRP2 levelsGCST902427275.49e-04
11598Whole body fat-free mass | Impedance measuresUKBB000009155.48e-04
11599Alcohol drinker status: current vs never (UKB data field 20117)GCST901329245.47e-04
11600ARHGAP25/RNF41 ratioGCST903133455.38e-04
11601MCAM/NCAM1 ratioGCST903154085.38e-04
11602S100G levelsGCST904705195.38e-04
11603aparc-DKTatlas rh volume precentralGCST900029155.32e-04
11604Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T215ECGU0002155.31e-04
11605Height (standard GWA)GCST902672845.31e-04
11606FVCGCST902786295.27e-04
11607SPINK1 levelsGCST904707215.24e-04
11608Lamb or mutton consumption (UKB data field 1379)GCST901329985.23e-04
11609Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T256ECGA0002565.22e-04
11610Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney diseaseGCST902651755.22e-04
11611HippSubfield rh volume CA4-bodyGCST900027055.20e-04
11612Barrett's esophagus (PheCode 530.13)GCST904760485.20e-04
11613Arthropathy NOS | musculoskeletalUKBB000000515.20e-04
11614Pulmonary embolism and infarction, acute (PheCode 415.11)GCST904759465.20e-04
11615ThalamNuclei lh volume MDlGCST900027245.18e-04
11616Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T494ECGA0004945.15e-04
11617Whole body water mass | Impedance measuresUKBB000009165.15e-04
11618Biliary cirrhosis, NASFING000002135.06e-04
11619IDP dMRI TBSS L2 Anterior limb of internal capsule LGCST900041405.05e-04
11620Volume of right anterior amygdaloid areaGCST904749045.03e-04
11621CTRB1 levelsGCST904689055.03e-04
11622Other bacterial intestinal infectionsFING000009695.00e-04
11623Right-hemisphere limbic network to thalamus white-matter structural connectivityGCST903028275.00e-04
11624DTI TBSS L3 Retrolenticular part of internal capsule LGCST903845455.00e-04
11625Standing height (UKB data field 50)GCST904681784.99e-04
11626Other diseases of intestine | Other diseases of intestinesUKBB000006054.97e-04
11627TRAF3 levelsGCST904709574.95e-04
11628Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000001674.90e-04
11629Left-hemisphere control network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027484.90e-04
11630Waist circumference adjusted for body mass indexGCST0122264.87e-04
11631T1 FreeSurfer aseg Left-PutamenGCST903841454.85e-04
11632Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T42ECGA0000424.84e-04
11633Left-hemisphere limbic network to putamen white-matter structural connectivityGCST903027384.83e-04
11634Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary AdministrationUKBB000004204.82e-04
11635Waist-hip ratioGCST902786494.82e-04
11636diastolic blood pressure (DBP, mean, inv-normal transformed)GCST904752554.81e-04
11637aparc-DKTatlas rh thickness paracentralGCST900035864.80e-04
11638Globe artichoke likingGCST900947714.77e-04
11639Descending aorta strainGCST902673894.77e-04
11640APP/NID2 ratioGCST903133274.75e-04
11641What is your height? (cm, inv-normal transformed)GCST904753684.72e-04
11642Body mass index (BMI, minimum, inv-normal transformed)GCST904751594.71e-04
11643Non-cancer illness code, self-reported - gastro-oesophageal reflux (gord) / gastric reflux | Medical conditionsUKBB000005104.70e-04
11644Macular puckerFING000007454.68e-04
11645Patient classification on admission (recoded) - Day case | Summary AdministrationUKBB000006364.68e-04
11646BTN2A1/SPINT2 ratioGCST903135504.66e-04
116471-methylhistidine levelsGCST901996914.65e-04
11648Daytime dozing / sleeping (narcolepsy) | SleepUKBB000001644.65e-04
11649Knee osteoarthritisGCST0070904.60e-04
11650PEAR1/SPINT2 ratioGCST903156444.58e-04
11651Normal-pressure hydrocephalusFING000008914.57e-04
11652X-12216 levelsGCST902004834.53e-04
11653Other septicaemiaFING000010974.51e-04
11654Atherosclerosis (PheCode 440)GCST904759894.51e-04
11655Variation in diet | DietUKBB000008924.51e-04
11656height (minimum, inv-normal transformed)GCST904753654.49e-04
11657Ischemic heart disease (PheCode 411)GCST0083704.49e-04
11658aseg lh volume Cerebellum-CortexGCST900026194.49e-04
11659Operation code - appendicectomy | OperationsUKBB000005494.48e-04
11660Diastolic blood pressure, manual reading | Blood pressureUKBB000001804.46e-04
11661Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000001784.44e-04
11662Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763)GCST904762684.42e-04
11663Body fat percentage (UKB data field 23099)GCST904681604.42e-04
11664Standing height | Body size measuresUKBB000007964.41e-04
11665Obesity | endocrine/metabolicUKBB000005444.37e-04
11666Prescriptions - bendroflumethiazide | thiazide diuretic,diureticUKBB000006674.33e-04
11667Trunk fat mass | Impedance measuresUKBB000008634.31e-04
11668T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST903206204.26e-04
11669T1 FreeSurfer DK lh MeanThickness thicknessGCST903856564.25e-04
11670BA-exvivo lh volume BA3bGCST900028384.23e-04
11671CRKL/DBNL ratioGCST903142634.22e-04
11672aparc-DKTatlas rh thickness lateraloccipitalGCST900035804.22e-04
11673Alcohol use and misuse (confirmatory factor analysis Factor 22)GCST903093564.21e-04
11674Other mental disorder | mental disordersUKBB000006144.21e-04
11675Other specified and unspecified disorders of lensFING000011014.19e-04
11676Retinal arteriolar tortuosityGCST902703974.18e-04
11677Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T43ECGA0000434.17e-04
11678Non-cancer illness code, self-reported - glaucoma | Medical conditionsUKBB000005114.11e-04
11679Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523FING000003044.10e-04
11680Sciatica+with lumbagoFING000012794.07e-04
11681Cardiomyopathy (excluding other)FING000002514.07e-04
11682IDP dMRI TBSS FA Anterior limb of internal capsule RGCST900038934.06e-04
11683Liver likingGCST900947944.04e-04
11684Obesity | Obesity and other hyperalimentationUKBB000005454.03e-04
116851-arachidonoylglycerophosphoinositol levelsGCST902437544.02e-04
11686aparc-DKTatlas lh volume lateraloccipitalGCST900028714.02e-04
11687Carotid intima-media thickness (MTAG)GCST904490614.02e-04
11688Left-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026784.01e-04
11689aparc-a2009s lh volume G-postcentralGCST900029523.97e-04
11690PCOLCE levelsGCST904701753.96e-04
11691AmbidextrousnessGCST900134203.96e-04
11692height (mean, inv-normal transformed)GCST904753623.96e-04
11693IDP T1 FAST ROIs L cerebellum XGCST900025873.95e-04
11694Height (maximum, inv-normal transformed)GCST904753593.94e-04
11695Body mass index (BMI, maximum, inv-normal transformed)GCST904751533.91e-04
11696Urbanicity (confirmatory factor analysis Factor 4)GCST903093393.89e-04
11697Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T201ECGA0002013.88e-04
11698Cryptic phenotype that captures Alport syndrome severityGCST901018283.85e-04
11699IDP dMRI TBSS L1 Posterior limb of internal capsule RGCST900040933.83e-04
11700T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 13)GCST903205763.80e-04
11701Left-hemisphere default mode network to thalamus white-matter structural connectivityGCST903027673.80e-04
11702ATXN10/SLC27A4 ratioGCST903133993.77e-04
11703O-sulfo-l-tyrosine levelsGCST902436233.77e-04
11704Glucose (fasting status unknown, maximum, inv-norm transformed)GCST904753293.77e-04
11705Dihexosylceramide (d18:1/24:0) levelsGCST900253493.77e-04
11706FAM3C levelsGCST904691873.76e-04
11707Type 1 diabetes with neurological manifestations (PheCode 250.14)GCST904756643.75e-04
11708HeightGCST900259493.74e-04
11709T1 FreeSurfer DKT rh supramarginal volumeGCST903843773.71e-04
11710aparc-DKTatlas lh volume postcentralGCST900028823.70e-04
11711Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T444ECGU0004443.70e-04
11712Forced expiratory volume in 1-second (FEV1) | SpirometryUKBB000002513.70e-04
11713Seated height | Body size measuresUKBB000007633.69e-04
11714OsteoarthritisGCST901342883.69e-04
11715T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST903208983.68e-04
11716IDP T1 FAST ROIs R hippocampusGCST900025563.68e-04
11717Hypertrophy of breast (Gynecomastia) (PheCode 612.2)GCST904761633.67e-04
11718Massiliomicrobiota abundance in stoolGCST900324703.67e-04
11719COL1A1 levelsGCST902407443.66e-04
11720Calculus of ureter (PheCode 594.3)GCST904761473.66e-04
11721Principal component-derived dietary pattern 29GCST901330343.65e-04
11722aseg global volume 4th-VentricleGCST900026003.62e-04
11723Current employment status - Retired | EmploymentUKBB000001593.61e-04
11724Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurementUKBB000001763.56e-04
11725BA-exvivo lh thickness V2GCST900035233.53e-04
11726Weight | Impedance measuresUKBB000009103.52e-04
11727Spontaneous coronary artery dissectionGCST902458783.50e-04
11728BMI (standard GWA)GCST902672683.47e-04
11729Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T493ECGA0004933.47e-04
11730Volume of left basal nucleusGCST904748773.47e-04
11731DTI autoptx L1 cst r tractGCST903851483.46e-04
11732EndometriosisFING000004973.45e-04
11733Moderate visual impairment, binocularFING000008313.45e-04
11734FEV1GCST0074323.41e-04
11735Left-hemisphere default mode network to caudate white-matter structural connectivityGCST903027683.39e-04
11736IDP T1 FAST ROIs R cerebellum XGCST900025893.39e-04
11737Diabetes mellitus (UKB data field 2443)GCST900436273.38e-04
11738InsomniaFING000006833.38e-04
11739Glaucoma | GlaucomaUKBB000002863.38e-04
11740Waist-hip indexGCST0122283.34e-04
11741systolic blood pressure (SBP, mean, inv-normal transformed)GCST904764033.31e-04
11742aparc-Desikan lh volume postcentralGCST900027893.29e-04
11743Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T205ECGA0002053.29e-04
11744JAM2 levelsGCST904696593.28e-04
11745Forced vital capacity (FVC) | SpirometryUKBB000002543.26e-04
11746T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 105)GCST903209243.24e-04
11747Body mass index (BMI, mean, inv-normal transformed)GCST904751563.18e-04
11748COL15A1 levelsGCST904688113.17e-04
11749Chronic bronchitisGCST900186043.16e-04
11750Myocardial infarction (PheCode 411.2)GCST900439543.14e-04
11751PPP1R14A levelsGCST904703023.14e-04
11752HNRNPAB levelsGCST900886933.12e-04
11753IDP T1 FAST ROIs L supracalc cortexGCST900025433.11e-04
11754Anaphylactic shock due to adverse effect of correct drug or medication properly administeredFING000000843.09e-04
11755Volume of left lateral nucleusGCST904748893.08e-04
11756Sebaceous cyst (PheCode 706.2)GCST904762133.08e-04
11757C21orf58 levelsGCST906183803.05e-04
11758Glucose levelsGCST900187353.04e-04
11759HAO1 levelsGCST904694292.97e-04
11760BA-exvivo lh volume BA4pGCST900028402.96e-04
11761DTI autoptx FA atr l tractGCST903851142.88e-04
11762Nasal polypsGCST904681432.88e-04
11763CPB1 levelsGCST902405972.87e-04
11764Waist-to-hip ratio adjusted for BMIGCST0122302.86e-04
11765Sitting height | Body size measuresUKBB000007712.86e-04
11766Overweight, obesity and other hyperalimentation | endocrine/metabolicUKBB000006222.86e-04
11767Smoking/smokers in household | SmokingUKBB000007832.85e-04
11768Phospholipid levels in large LDLGCST901326482.84e-04
11769aparc-a2009s lh area S-collat-transv-antGCST900033462.83e-04
11770aseg rh volume Lateral-VentricleGCST900026332.81e-04
11771LY6D levelsGCST904698212.79e-04
11772Osteoporosis (PheCode 743.1)GCST904763842.79e-04
11773aparc-pial lh area TotalSurfaceGCST900031412.78e-04
11774Impedance of leg (left) | Impedance measuresUKBB000003582.77e-04
11775Volume of right lateral nucleusGCST904750362.77e-04
11776T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 50)GCST903206132.74e-04
11777Bicarbonate (maximum, inv-norm transformed)GCST904751452.71e-04
11778DTI autoptx FA ilf l tractGCST903851262.70e-04
11779Left ventricular end diastole anterospetal wall thicknessGCST902785192.70e-04
11780Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T41ECGA0000412.70e-04
11781IGFBPL1 levelsGCST901793232.68e-04
11782MIF levelsGCST904699062.65e-04
11783Non-cancer illness code, self-reported - osteoarthritis | Medical conditionsUKBB000005212.64e-04
11784Other and unspecified polyneuropathies, also in other diseasesFING000009482.64e-04
11785High blood pressure / hypertensionGCST904752142.62e-04
11786Peak expiratory flow (UKB data field 3064)GCST904681762.61e-04
11787DTI TBSS MD Retrolenticular part of internal capsule RGCST903845922.59e-04
11788DTI TBSS FA Anterior corona radiata RGCST903844022.59e-04
11789Ventricular arrhythmiaGCST900187202.52e-04
11790Diacylglycerol_36:5_[M+H-H2O]1+ levelsGCST900601872.51e-04
11791IDP dMRI ProbtrackX ISOVF str rGCST900045492.51e-04
11792Mean volume of bilateral amygdalaGCST904749012.51e-04
11793Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T500ECGA0005002.51e-04
11794Fracture of shoulder and upper armFING000005592.50e-04
11795aparc-Desikan rh thickness lateraloccipitalGCST900034892.50e-04
11796Body mass index (MTAG)GCST901791502.50e-04
11797Left-hemisphere somatomotor network to left-hemisphere limbic network white-matter structural connectivityGCST903026722.49e-04
11798IDP dMRI TBSS L3 Superior fronto-occipital fasciculus LGCST900042142.49e-04
11799Concentration of LDL particlesGCST904984182.48e-04
11800Sphingomyelin (d18:1/20:0, d16:1/22:0) levelsGCST902000012.48e-04
11801DTI TBSS MD Fornix cres+Stria terminalis RGCST903846102.48e-04
11802T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 70)GCST903208892.48e-04
11803IDP dMRI TBSS L1 Splenium of corpus callosumGCST900040792.47e-04
11804T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117)GCST903206802.46e-04
11805Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 7.99_210.09)GCST902913122.44e-04
11806Appendicular lean massGCST900000252.43e-04
11807Basal metabolic rate (UKB data field 23105)GCST904681592.42e-04
11808PDZK1 levelsGCST904702032.42e-04
11809Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T213ECGU0002132.39e-04
11810Forced expiratory volume in 1 second FEV1 Z score (UKB data field 20256)GCST904681662.39e-04
11811CEACAM1/GGT1 ratioGCST903140002.37e-04
11812Operation code - caesarean section / caesarian section | OperationsUKBB000005522.36e-04
11813Operation code - hip replacement/revision | OperationsUKBB000005582.36e-04
11814Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19ECGA0000192.36e-04
11815Melanocytic naeviFING000007972.35e-04
11816Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472ECGU0004722.34e-04
11817IDP dMRI TBSS L1 Cerebral peduncle RGCST900040892.34e-04
11818Weight | Body size measuresUKBB000009092.34e-04
118194-androsten-3beta,17beta-diol disulfate 2 levelsGCST902438802.33e-04
11820X-23641 levelsGCST902006032.33e-04
11821ICD10 C61: Malignant neoplasm of prostateGCST900438942.33e-04
11822Acute pulmonary heart disease (PheCode 415.1)GCST904759442.30e-04
11823NTRK3/SCARF2 ratioGCST903155712.30e-04
11824Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressureUKBB000003772.28e-04
11825T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST903208762.25e-04
11826GGT1/IL1RL2 ratioGCST903149292.24e-04
118273-(4-hydroxyphenyl)lactate levelsGCST902435752.22e-04
11828Irritable bowel syndromeFING000007022.21e-04
11829Blood urea nitrogen (BUN, mean, inv-norm transformed)GCST904751652.21e-04
11830Blood cell traits latent factor 6 (red cell (and basophil))GCST905592482.21e-04
11831Subpubic angleGCST904489082.18e-04
11832Free cholesterol levels in large LDLGCST0036652.16e-04
11833Left-hemisphere somatomotor network to left-hemisphere somatomotor network white-matter structural connectivityGCST903026692.15e-04
11834IDP dMRI ProbtrackX L1 str rGCST900042702.14e-04
11835Infective dermatitisFING000006732.13e-04
11836Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442ECGU0004422.12e-04
11837Right-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivityGCST903028052.12e-04
11838Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T466ECGU0004662.11e-04
11839Dermatitis due to ingested foodFING000004032.09e-04
11840CardiomyopathyFING000002502.08e-04
11841SMOC2 levelsGCST904227732.08e-04
11842KIRREL2/PLA2G1B ratioGCST903152512.06e-04
11843Cancer of prostate | neoplasmsUKBB000001182.06e-04
11844AMY2A levelsGCST904682982.05e-04
11845Calculus of kidney | genitourinaryUKBB000001152.02e-04
11846Concentration of large LDL particlesGCST904980292.01e-04
11847SWAP70 levelsGCST902429312.01e-04
11848Viral warts & HPV (PheCode 78)GCST904755551.99e-04
11849IDP dMRI TBSS MO Superior corona radiata RGCST900039761.98e-04
11850IDP dMRI TBSS L1 External capsule RGCST900041071.98e-04
11851Serum urea levelsGCST900259911.95e-04
11852Vertical cup-disc ratioGCST0040751.95e-04
11853Principal component-derived dietary pattern 5GCST901330101.95e-04
11854rfMRI connectivity (ICA100 edge 399)GCST900052521.94e-04
11855Operation code - bilateral oophorectomy | OperationsUKBB000005501.92e-04
11856Mild age-related type 2 diabetesGCST900264161.91e-04
11857Total cholesterol levels in LDLGCST901326861.89e-04
11858Malignant neoplasm of female breast (PheCode 174.11)GCST900418331.89e-04
11859Retinal detachments and defects (PheCode 361)GCST904758451.87e-04
11860aparc-a2009s lh area S-temporal-supGCST900033691.87e-04
11861CholelithiasisFING000002751.86e-04
11862aparc-Desikan lh volume lateraloccipitalGCST900027781.85e-04
11863T1 FreeSurfer aseg Right-choroid-plexusGCST903841701.85e-04
11864Total bile acid levels in pregnancyGCST904541981.82e-04
11865CELA3A/KIRREL2 ratioGCST903140131.82e-04
11866Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST904993351.80e-04
11867Cerebrospinal fluid S-1-pyrroline-5-carboxylate levelsGCST903182351.80e-04
11868Anemia in chronic kidney disease (PheCode 285.21)GCST904757921.79e-04
11869ThalamNuclei rh volume VLpGCST900027551.79e-04
11870Glaucoma | sense organsUKBB000002871.79e-04
11871FAM3B levelsGCST904691861.78e-04
11872Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17ECGA0000171.77e-04
11873End-diastolic bi-ventricular shape (principal component 2)GCST904484811.77e-04
11874Illnesses of siblings - None of the above (group 1) | Family historyUKBB000003531.76e-04
11875Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007981.76e-04
11876FGF2 levelsGCST904692241.76e-04
11877Forced expiratory volume (baseline)GCST905658441.76e-04
11878Number of sexual partners in opposite-sex sexual behaviorGCST900264821.75e-04
11879Deaf mutism, not elsewhere classifiedFING000003781.75e-04
11880T1 CAT volume R SupramarginalGyrusanteriordivisionGCST903840371.75e-04
11881Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486ECGA0004861.72e-04
11882aparc-pial lh area cuneusGCST900031451.72e-04
11883Transport type for commuting to job workplace - Public transport | EmploymentUKBB000008281.70e-04
11884BA-exvivo lh volume entorhinalGCST900028481.69e-04
11885Adenocarcinoma and papilloma adenocarcinoma of rectumFING000000391.68e-04
11886Appendicular lean massGCST900000271.67e-04
11887ARG1 levelsGCST904683501.64e-04
11888Colonic or urogenital fistulaFING000003151.64e-04
11889Calculus of kidney (PheCode 594.1)GCST904761451.63e-04
11890VitiligoFING000014431.63e-04
11891Stearate 18:0 levelsGCST902434311.63e-04
11892acne vulgarisGCST902458181.61e-04
11893Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T498ECGA0004981.60e-04
11894Takes medication for prostate cancer?GCST904751871.60e-04
11895Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470ECGU0004701.58e-04
118961-stearoyl-2-arachidonoyl-GPC (18:0/20:4) metabolite levelGCST906156701.58e-04
11897Treatment speciality of consultant (recoded) - Urology | Summary AdministrationUKBB000008381.56e-04
11898Posterior thigh muscle volumeGCST902673531.56e-04
11899IDP dMRI TBSS ISOVF Superior corona radiata RGCST900045011.55e-04
11900Trigger fingerGCST901049071.53e-04
11901aparc-DKTatlas lh volume parstriangularisGCST900028801.53e-04
11902Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)FING000007551.52e-04
11903Left-hemisphere default mode network to accumbens white-matter structural connectivityGCST903027731.51e-04
11904IDP dMRI ProbtrackX L2 atr lGCST900042751.51e-04
11905KRT19 levelsGCST904697171.51e-04
11906HSPG2 levelsGCST901793921.49e-04
11907Comparative body size at age 10 | Early life factorsUKBB000001421.49e-04
11908CDON levelsGCST904686871.49e-04
11909Frailty (Factor 3 - Multimorbidity)GCST906240491.49e-04
11910OsteomyelitisFING000009111.48e-04
11911KeratitisFING000007081.47e-04
11912Intended management of patient (recoded) - No overnight hospital stay | Summary AdministrationUKBB000003661.47e-04
11913UrolithiasisGCST900187151.47e-04
11914Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T255ECGA0002551.45e-04
11915What is your weight? (pounds, inv-normal transformed)GCST904764691.42e-04
11916Endometrial cancerGCST0064641.42e-04
11917Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)FING000007661.42e-04
11918Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471ECGU0004711.40e-04
11919Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12ECGA0000121.40e-04
11920DTI TBSS L2 Anterior corona radiata RGCST903844981.40e-04
11921CPA1/CTRC ratioGCST903142041.37e-04
11922PGA4 levelsGCST904702161.37e-04
11923IDP T1 FIRST right caudate volumeGCST900024391.36e-04
11924Sexual abuseGCST905518371.36e-04
11925F-strong vegetable liking (derived food-liking factor)GCST900948521.33e-04
11926Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16ECGA0000161.33e-04
11927LSIL lesion of the cervix uteriFING000007321.32e-04
11928aparc-a2009s rh volume G-cuneusGCST900030091.31e-04
11929Whole body water mass (UKB data field 23102)GCST904681841.31e-04
11930Other arthrosisFING000009651.29e-04
11931aparc-a2009s rh area G-cuneusGCST900033811.26e-04
11932Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factorsUKBB000000581.26e-04
11933Enlarged prostate (Benign prostatic hyperplasia)GCST904752611.25e-04
11934T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3)GCST903208221.25e-04
11935Other disorders of patellaFING000010321.25e-04
11936APOB levelsGCST904971301.25e-04
11937Operation code - hysterectomy | OperationsUKBB000005591.24e-04
11938DTI TBSS MO Corticospinal tract RGCST903846261.23e-04
11939Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 8.07_212.10)GCST902918051.23e-04
11940Other intervertebral disc disordersFING000010631.23e-04
11941aparc-a2009s lh volume G-cuneusGCST900029351.22e-04
11942Anemia of chronic disease (PheCode 285.2)GCST904757901.22e-04
11943Fat-free massGCST0070631.21e-04
11944Mother's age | Family historyUKBB000004841.17e-04
11945Prescriptions - prostaglandin analogUKBB000006971.17e-04
11946Father's age | Family historyUKBB000002401.16e-04
11947Volume of left anterior amygdaloid areaGCST904749371.15e-04
11948Height (weighted GWA)GCST902672851.14e-04
11949STROKEFING000013361.14e-04
11950Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedFING000004311.13e-04
11951Gamma glutamyltransferase | Blood biochemistryUKBB000002751.12e-04
11952Glucose levels (UKB data field 30740)GCST904680711.12e-04
11953T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68)GCST903206311.12e-04
11954Physical activity (Total log acceleration 12am-2am)GCST900614091.11e-04
11955T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46)GCST903206091.09e-04
11956Fracture of hand or wrist (PheCode 804)GCST904762811.09e-04
11957Osteoarthritis (hip)GCST0070911.09e-04
11958aseg rh volume choroid-plexusGCST900026461.07e-04
11959aparc-DKTatlas lh thickness lateraloccipitalGCST900035491.06e-04
11960Urine X-23518 levels in chronic kidney diseaseGCST902665951.06e-04
11961Peak expiratory flowGCST0074301.05e-04
11962Volume of left whole amygdalaGCST904748981.04e-04
11963Urinary calculus (PheCode 594)GCST904761431.04e-04
11964IDP dMRI TBSS L3 Anterior limb of internal capsule LGCST900041881.04e-04
11965Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)FING000008651.03e-04
11966LSIL lesion of the cervix uteri, vagina or vulvaFING000007331.03e-04
11967Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T208ECGA0002081.01e-04
11968Retinal venular tortuosityGCST902703991.01e-04
11969Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6ECGA0000069.98e-05
11970CPB1 levelsGCST904688399.97e-05
11971Alcohol consumptionGCST901330039.97e-05
11972CPB1/CTRC ratioGCST903142099.93e-05
11973Other disorders of intestine | digestiveUKBB000006089.93e-05
11974Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478ECGU0004789.90e-05
11975Hypertensive heart and/or renal disease (PheCode 401.2)GCST904759249.72e-05
11976Body mass index (UKB data field 21001)GCST904681619.71e-05
11977Prescriptions - thiazide diuretic|diureticUKBB000007049.64e-05
11978aparc-Desikan lh area postcentralGCST900030949.58e-05
11979Left-hemisphere control network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027469.49e-05
11980End-diastolic bi-ventricular shape (principal component 5)GCST904484849.47e-05
11981Lumbar disc prolapseFING000007359.40e-05
11982Fresh fruit consumptionGCST901329799.39e-05
11983CPB1/CTRB1 ratioGCST903142089.38e-05
11984ScoliosisFING000012819.32e-05
11985Paracetamol of NSAID medicationFING000011459.32e-05
11986Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T31ECGA0000319.30e-05
11987IDP T1 FAST ROIs R caudateGCST900025509.19e-05
11988Cancer of prostate (PheCode 185)GCST900418539.10e-05
11989CPB1/KIRREL2 ratioGCST903142109.01e-05
11990Retinal thickness (functional principal component 4)GCST904557249.00e-05
11991aparc-Desikan lh volume cuneusGCST900027728.98e-05
11992Retinal detachments and breaks | Disorders of choroid and retinaUKBB000007558.94e-05
11993Diabetes (weighted GWA)GCST902672798.93e-05
11994T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 20)GCST903208398.82e-05
11995T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52)GCST903208718.82e-05
11996Illnesses of siblings - Diabetes | Family historyUKBB000003508.78e-05
11997Other reaction to severe stress, and adjustment disordersFING000010928.77e-05
11998Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T35ECGA0000358.67e-05
11999aparc-a2009s lh thickness G-postcentralGCST900036308.58e-05
12000Erythronate levelsGCST902436968.45e-05